Cargando…

Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms

Mostrar otras versiones (2)

Detalles Bibliográficos
Autores principales:	Schäfer, S. A., Tschritter, O., Machicao, F., Thamer, C., Stefan, N., Gallwitz, B., Holst, J. J., Dekker, J. M., t’Hart, L. M., Nijpels, G., van Haeften, T. W., Häring, H. U., Fritsche, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2009
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969944/ http://dx.doi.org/10.1007/s00125-008-1248-9

Ejemplares similares

Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms
por: Schäfer, S. A., et al.
Publicado: (2007)

Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms
por: Schäfer, S. A., et al.
Publicado: (2007)

Dietary Fiber Intake Modulates the Association Between Variants in TCF7L2 and Weight Loss During a Lifestyle Intervention
por: Heni, Martin, et al.
Publicado: (2012)

Clinical and non-targeted metabolomic profiling of homozygous carriers of Transcription Factor 7-like 2 variant rs7903146
por: Wagner, Robert, et al.
Publicado: (2014)

Gene Variants of TCF7L2 Influence Weight Loss and Body Composition During Lifestyle Intervention in a Population at Risk for Type 2 Diabetes
por: Haupt, Axel, et al.
Publicado: (2010)

Polymorphisms within Novel Risk Loci for Type 2 Diabetes Determine β-Cell Function
por: Staiger, Harald, et al.
Publicado: (2007)

Impact of the TCF7L2 genotype on risk of hypoglycaemia and glucagon secretion during hypoglycaemia
por: Kristensen, Peter L, et al.
Publicado: (2016)

Association of Type 2 Diabetes Candidate Polymorphisms in KCNQ1 With Incretin and Insulin Secretion
por: Müssig, Karsten, et al.
Publicado: (2009)

DPP4 gene variation affects GLP-1 secretion, insulin secretion, and glucose tolerance in humans with high body adiposity
por: Böhm, Anja, et al.
Publicado: (2017)

Stability of glucagon-like peptide 1 and glucagon in human plasma
por: Wewer Albrechtsen, Nicolai J, et al.
Publicado: (2015)

Transcription Factor-7-Like-2 (TCF7L2) in Atherosclerosis: A Potential Biomarker and Therapeutic Target
por: Li, Junyi, et al.
Publicado: (2021)

Untangling the interplay of genetic and metabolic influences on beta-cell function: Examples of potential therapeutic implications involving TCF7L2 and FFAR1()
por: Wagner, Robert, et al.
Publicado: (2014)

The incretin/glucagon system as a target for pharmacotherapy of obesity
por: Del Prato, Stefano, et al.
Publicado: (2021)

Serotonin is elevated in risk-genotype carriers of TCF7L2 - rs7903146
por: Leiherer, Andreas, et al.
Publicado: (2019)

Transcription Factor 7-Like 2 (TCF7L2) Polymorphism and Hyperglycemia in an Adult Italian Population-Based Cohort
por: Gambino, Roberto, et al.
Publicado: (2010)

Impact of transcription factor 7-like 2 (TCF7L2) on pancreatic islet function and morphology in mice and men
por: Renström, E.
Publicado: (2012)

Glucagon-like peptide 1 (GLP-1)
por: Müller, T.D., et al.
Publicado: (2019)

Cerebrocortical Beta Activity in Overweight Humans Responds to Insulin Detemir
por: Tschritter, Otto, et al.
Publicado: (2007)

The Effect of Glucagon-Like Peptide-2 Receptor Agonists on Colonic Anastomotic Wound Healing
por: Redstone, Heather A., et al.
Publicado: (2010)

Polymorphism of Transcription Factor-7-Like 2 (TCF7L2) Gene and New-Onset Diabetes after Liver Transplantation
por: Musavi, Z., et al.
Publicado: (2015)

Association of the Transcription Factor 7 Like 2 (TCF7L2) Polymorphism With Diabetic Nephropathy Risk: A Meta-Analysis
por: Fan, Zhenqian, et al.
Publicado: (2016)

SIRT1 genetic variants associate with the metabolic response of Caucasians to a controlled lifestyle intervention – the TULIP Study
por: Weyrich, Peter, et al.
Publicado: (2008)

An Obesity Risk SNP (rs17782313) near the MC4R Gene Is Associated with Cerebrocortical Insulin Resistance in Humans
por: Tschritter, Otto, et al.
Publicado: (2011)

Transcription factor 7-like 2 (TCF7L2) gene polymorphism and clinical phenotype in end-stage renal disease patients
por: Buraczynska, Monika, et al.
Publicado: (2014)

Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study
por: Burwinkel, Barbara, et al.
Publicado: (2006)

Association of transcription factor 7-like 2 (TCF7L2) gene polymorphism with type 2 diabetes mellitus in Chinese Korean ethnicity population
por: Zhou, Kui-Chen, et al.
Publicado: (2019)

The transcription factor 7-like 2 (TCF7L2) polymorphism may be associated with focal arteriolar narrowing in Caucasians with hypertension or without diabetes: the ARIC Study
por: Yan, Yu, et al.
Publicado: (2010)

Glycemia Determines the Effect of Type 2 Diabetes Risk Genes on Insulin Secretion
por: Heni, Martin, et al.
Publicado: (2010)

Tcf7l1 promotes transcription of Kruppel-like factor 4 during Xenopus embryogenesis
por: Cao, Qing, et al.
Publicado: (2018)

Pancreatic alpha cell-selective deletion of Tcf7l2 impairs glucagon secretion and counter-regulatory responses to hypoglycaemia in mice
por: da Silva Xavier, Gabriela, et al.
Publicado: (2017)

Common variation in the sodium/glucose cotransporter 2 gene SLC5A2 does neither affect fasting nor glucose-suppressed plasma glucagon concentrations
por: Ordelheide, Anna-Maria, et al.
Publicado: (2017)

TCF7 is not essential for glucose homeostasis in mice
por: Kaur, Kiran Deep, et al.
Publicado: (2021)

Rapid Tachyphylaxis of the Glucagon-Like Peptide 1–Induced Deceleration of Gastric Emptying in Humans
por: Nauck, Michael A., et al.
Publicado: (2011)

Transcription Factor 7-Like 2 (TCF7L2) rs7903146 Polymorphism as a Risk Factor for Gestational Diabetes Mellitus: A Meta-Analysis
por: Lin, Pei-Chao, et al.
Publicado: (2016)

Tissue-specific alternative splicing of TCF7L2
por: Prokunina-Olsson, Ludmila, et al.
Publicado: (2009)

Associations of transcription factor 7-Like 2 (TCF7L2) gene polymorphism in patients of type 2 diabetes mellitus from Khyber Pakhtunkhwa population of Pakistan
por: Hameed, Taha, et al.
Publicado: (2021)

The Role of TCF7L2 in Type 2 Diabetes
por: del Bosque-Plata, Laura, et al.
Publicado: (2021)

Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
por: Ammann, Markus, et al.
Publicado: (2023)

Association of obesity risk SNPs in PCSK1 with insulin sensitivity and proinsulin conversion
por: Heni, Martin, et al.
Publicado: (2010)

The D299G/T399I Toll-Like Receptor 4 Variant Associates with Body and Liver Fat: Results from the TULIP and METSIM Studies
por: Weyrich, Peter, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_k421k2dtrdnobva5oej61der6e